Back to Search Start Over

A functional variant in NEPH3 gene confers high risk of renal failure in primary hematuric glomerulopathies. Evidence for predisposition to microalbuminuria in the general population

Authors :
Voskarides, Konstantinos
Stefanou, Charalambos
Pieri, Myrtani
Demosthenous, Panayiota
Felekkis, Kyriakos
Arsali, Maria
Athanasiou, Yiannis
Xydakis, Dimitris
Stylianou, Kostas
Daphnis, Eugenios
Goulielmos, Giorgos
Loizou, Petros
Savige, Judith
Hoehne, Martin
Voelker, Linus A.
Benzing, Thomas
Maxwell, Patrick H.
Gale, Daniel P.
Gorski, Mathias
Boeger, Carsten
Kollerits, Barbara
Kronenberg, Florian
Paulweber, Bernhard
Zavros, Michalis
Pierides, Alkis
Deltas, Constantinos
Voskarides, Konstantinos
Stefanou, Charalambos
Pieri, Myrtani
Demosthenous, Panayiota
Felekkis, Kyriakos
Arsali, Maria
Athanasiou, Yiannis
Xydakis, Dimitris
Stylianou, Kostas
Daphnis, Eugenios
Goulielmos, Giorgos
Loizou, Petros
Savige, Judith
Hoehne, Martin
Voelker, Linus A.
Benzing, Thomas
Maxwell, Patrick H.
Gale, Daniel P.
Gorski, Mathias
Boeger, Carsten
Kollerits, Barbara
Kronenberg, Florian
Paulweber, Bernhard
Zavros, Michalis
Pierides, Alkis
Deltas, Constantinos
Publication Year :
2017

Abstract

Background Recent data emphasize that thin basement membrane nephropathy (TBMN) should not be viewed as a form of benign familial hematuria since chronic renal failure (CRF) and even end-stage renal disease (ESRD), is a possible development for a subset of patients on longterm follow-up, through the onset of focal and segmental glomerulosclerosis (FSGS). We hypothesize that genetic modifiers may explain this variability of symptoms. Methods We looked in silico for potentially deleterious functional SNPs, using very strict criteria, in all the genes significantly expressed in the slit diaphragm (SD). Two variants were genotyped in a cohort of well-studied adult TBMN patients from 19 Greek-Cypriot families, with a homogeneous genetic background. Patients were categorized as Severe or Mild, based on the presence or not of proteinuria, CRF and ESRD. A larger pooled cohort (HEMATURIA) of 524 patients, including IgA nephropathy patients, was used for verification. Additionally, three large general population cohorts [Framingham Heart Study (FHS), KORAF4 and SAPHIR] were used to investigate if the NEPH3-V353M variant has any renal effect in the general population. Results and conclusions Genotyping for two high-scored variants in 103 TBMN adult patients with founder mutations who were classified as mildly or severely affected, pointed to an association with variant NEPH3-V353M (filtrin). This promising result prompted testing in the larger pooled cohort (HEMATURIA), indicating an association of the 353M variant with disease severity under the dominant model (p = 3.0x10(-3), OR = 6.64 adjusting for gender/age; allelic association: p = 4.2x10(-3) adjusting for patients' kinships). Subsequently, genotyping 6,531 subjects of the Framingham Heart Study (FHS) revealed an association of the homozygous 353M/M genotype with microalbuminuria (p = 1.0x10(-3)). Two further general population cohorts, KORAF4 and SAPHIR confirmed the association, and a meta-analysis of all three cohorts

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1201324946
Document Type :
Electronic Resource